Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-SUCRALFATE 1G TABLET Resolved 2019-08-29 2020-01-30 92663
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92669
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-11-08 92672
TEVA-NABILONE 0.5MG CAPSULE Resolved 2019-08-29 2019-11-21 92675
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92678
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92681
ACT SUMATRIPTAN 100MG TABLET Resolved 2019-08-29 2020-07-10 92684
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2019-09-05 2019-12-19 93131
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2019-09-05 2019-09-27 93134
TEVA-MODAFINIL 100MG TABLET Resolved 2019-09-05 2019-10-04 93137
PEMETREXED DISODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-10-17 93140
TEVA-TADALAFIL 10MG TABLET Resolved 2019-09-05 2019-09-27 93143
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2019-09-05 2020-02-08 93146
TEVA-SOLIFENACIN 5MG TABLET Resolved 2019-09-05 2020-04-09 93149
TEVA-TOLTERODINE 1MG TABLET Resolved 2019-09-05 2021-07-22 93152
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
TEVA-LATANOPROST 0.05MG SOLUTION Resolved 2019-09-05 2020-07-10 93159
RATIO-METFORMIN 850MG TABLET Resolved 2019-09-05 2020-07-10 93162

Showing 701 to 720 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-FAMOTIDINE 20MG TABLET Discontinued 2019-04-11 2019-04-11 81371
TEVA-PREDNISONE 5MG TABLET Discontinued 2019-04-11 2019-04-11 81376
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81381
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 101 to 120 of 250